Health
A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability – News-Medical.Net
Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern…
Researchers tested a vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.
The emergence of several new mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to concerns about increased transmissibility of the virus and the ability of vaccines to protect against them. Some studies point to lower efficacy of vaccines to the new strains compared to…
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General22 hours agoThree maps that show the scale of the NSW flood disaster
-
General12 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws